Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome.
作者信息
Ding Yanna, Dulau-Florea Alina E, Groarke Emma M, Patel Bhavisha A, Beck David B, Grayson Peter C, Ferrada Marcela A, Young Neal S, Calvo Katherine R, Braylan Raul C
机构信息
Laboratory of Pathology, Hematopathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Department of Laboratory Medicine, Hematology Section, Clinical Center, Bethesda, MD.
出版信息
Blood Adv. 2023 Oct 24;7(20):6151-6155. doi: 10.1182/bloodadvances.2023010456.
Abstract
摘要
相似文献
1
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome.
Blood Adv. 2023 Oct 24;7(20):6151-6155. doi: 10.1182/bloodadvances.2023010456.
2
VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation.
Eur J Haematol. 2023 Jun;110(6):633-638. doi: 10.1111/ejh.13944. Epub 2023 Feb 22.
3
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Semin Hematol. 2021 Oct;58(4):204-211. doi: 10.1053/j.seminhematol.2021.10.007. Epub 2021 Oct 22.
4
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
Arthritis Rheumatol. 2022 Apr;74(4):665-670. doi: 10.1002/art.41992. Epub 2022 Mar 3.
5
UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.
Mod Rheumatol Case Rep. 2022 Jan 7;6(1):134-139. doi: 10.1093/mrcr/rxab021.
6
VEXAS syndrome in dermatology.
Arch Dermatol Res. 2023 Mar;315(2):161-164. doi: 10.1007/s00403-022-02340-4. Epub 2022 Feb 24.
7
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
Int J Hematol. 2023 Oct;118(4):494-502. doi: 10.1007/s12185-023-03598-8. Epub 2023 Apr 17.
8
Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome.
Med Clin (Barc). 2022 Nov 25;159(10):489-496. doi: 10.1016/j.medcli.2022.06.018. Epub 2022 Aug 29.
9
A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma.
BMC Rheumatol. 2023 Jul 10;7(1):18. doi: 10.1186/s41927-023-00343-w.
10
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Clin Rheumatol. 2022 Nov;41(11):3565-3572. doi: 10.1007/s10067-022-06338-1. Epub 2022 Aug 20.
引用本文的文献
1
Human neutrophils are a cellular source of apolipoprotein A-I.
J Leukoc Biol. 2025 Jul 9;117(7). doi: 10.1093/jleuko/qiaf104.
2
Comprehensive bioinformatics analysis and experimental verification identify mitochondrial gene Dgat2 as a novel therapeutic biomarker for myocardial ischemia-reperfusion.
Front Endocrinol (Lausanne). 2025 May 29;16:1539646. doi: 10.3389/fendo.2025.1539646. eCollection 2025.
3
Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis.
Cell Mol Immunol. 2025 Mar;22(3):316-329. doi: 10.1038/s41423-025-01259-w. Epub 2025 Feb 13.
本文引用的文献
1
Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome.
Hemasphere. 2023 Jan 25;7(2):e828. doi: 10.1097/HS9.0000000000000828. eCollection 2023 Feb.
2
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
JAMA. 2023 Jan 24;329(4):318-324. doi: 10.1001/jama.2022.24836.
3
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Semin Hematol. 2021 Oct;58(4):204-211. doi: 10.1053/j.seminhematol.2021.10.007. Epub 2021 Oct 22.
4
VEXAS syndrome: An inflammatory and hematologic disease.
Semin Hematol. 2021 Oct;58(4):201-203. doi: 10.1053/j.seminhematol.2021.10.005. Epub 2021 Oct 14.
5
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Br J Dermatol. 2022 Mar;186(3):564-574. doi: 10.1111/bjd.20805. Epub 2021 Nov 28.
6
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Blood Adv. 2021 Aug 24;5(16):3203-3215. doi: 10.1182/bloodadvances.2021004976.
7
Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
Br J Haematol. 2021 Oct;195(2):286-289. doi: 10.1111/bjh.17679. Epub 2021 Aug 2.
8
VEXAS syndrome.
Blood. 2021 Jul 1;137(26):3591-3594. doi: 10.1182/blood.2021011455.
9
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder.
Exp Hematol Oncol. 2021 Mar 19;10(1):23. doi: 10.1186/s40164-021-00217-2.
10
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies.
Blood. 2021 Jul 1;137(26):3685-3689. doi: 10.1182/blood.2021010811.
Zotero 插件